Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation

Aspergillus fumigatus is an important airborne fungal pathogen and a major cause of invasive fungal infections. Susceptible individuals become infected via the inhalation of dormant conidia. If the immune system fails to clear these conidia, they will swell, germinate and grow into large hyphal structures. Neutrophils are essential effector cells for controlling A. fumigatus infection. In general, opsonization of microbial particles is crucial for efficient phagocytosis and killing by neutrophils. Although the antibodies present in human serum do bind to all fungal morphotypes, we observed no direct antibody-mediated phagocytosis of A. fumigatus. We show that opsonization, phagocytosis and killing by neutrophils of A. fumigatus is complement-dependent. Using human sera depleted of key complement components, we investigated the contribution of the different complement initiation pathways in complement activation on the fungal surface. We describe the classical complement pathway as the main initiator of complement activation on A. fumigatus swollen conidia and germ tubes. Antibodies play an important role in complement activation and efficient innate recognition, phagocytosis and killing of A. fumigatus by neutrophils.

[1]  Evelien T. M. Berends,et al.  Bacteria under stress by complement and coagulation. , 2014, FEMS microbiology reviews.

[2]  Md. Arif Sheikh,et al.  Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation , 2013, Proceedings of the National Academy of Sciences.

[3]  J. Köhl,et al.  Staphylococcus aureus Formyl Peptide Receptor–like 1 Inhibitor (FLIPr) and Its Homologue FLIPr-like Are Potent FcγR Antagonists That Inhibit IgG-Mediated Effector Functions , 2013, The Journal of Immunology.

[4]  Michelle Momany,et al.  Fungal antioxidant pathways promote survival against neutrophils during infection. , 2012, The Journal of clinical investigation.

[5]  J. Latgé,et al.  Galactosaminogalactan, a New Immunosuppressive Polysaccharide of Aspergillus fumigatus , 2011, PLoS pathogens.

[6]  P. Taylor,et al.  Class IA Phosphoinositide 3-Kinase β and δ Regulate Neutrophil Oxidase Activation in Response to Aspergillus fumigatus Hyphae , 2011, The Journal of Immunology.

[7]  D. Stevens,et al.  Aspergillosis in the ‘Nonimmunocompromised’ Host , 2011, Immunological investigations.

[8]  M. Ghannoum,et al.  Distinct Roles for Dectin-1 and TLR4 in the Pathogenesis of Aspergillus fumigatus Keratitis , 2010, PLoS pathogens.

[9]  D. Stevens,et al.  Resistance of MBL gene-knockout mice to experimental systemic aspergillosis. , 2010, Immunology letters.

[10]  T. Hohl,et al.  Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. , 2009, The Journal of infectious diseases.

[11]  T. Schoeb,et al.  Requisite Role for the Dectin-1 β-Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus 1 , 2009, The Journal of Immunology.

[12]  R. Grillot,et al.  Aspergillus Conidia Activate the Complement by the Mannan-Binding Lectin C2 Bypass Mechanism1 , 2008, The Journal of Immunology.

[13]  H. Fuller,et al.  Prevalence of culturable airborne spores of selected allergenic and pathogenic fungi in outdoor air , 2008 .

[14]  A. Hartmann,et al.  The Opportunistic Human Pathogenic Fungus Aspergillus fumigatus Evades the Host Complement System , 2007, Infection and Immunity.

[15]  Kyung J. Kwon-Chung,et al.  Human Polymorphonuclear Leukocytes Inhibit Aspergillus fumigatus Conidial Growth by Lactoferrin-Mediated Iron Depletion1 , 2007, The Journal of Immunology.

[16]  P. Lenting,et al.  Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. , 2007, Blood.

[17]  S. Gordon,et al.  The Beta-Glucan Receptor Dectin-1 Recognizes Specific Morphologies of Aspergillus fumigatus , 2005, PLoS pathogens.

[18]  Robert B Sim,et al.  Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases , 2005, Nature Immunology.

[19]  A. Mantovani,et al.  The Contribution of the Toll-Like/IL-1 Receptor Superfamily to Innate and Adaptive Immunity to Fungal Pathogens In Vivo1 , 2004, The Journal of Immunology.

[20]  T. Kozel,et al.  Biological Activities of Naturally Occurring Antibodies Reactive with Candida albicans Mannan , 2004, Infection and Immunity.

[21]  Christine Gaboriaud,et al.  The Crystal Structure of the Globular Head of Complement Protein C1q Provides a Basis for Its Versatile Recognition Properties* , 2003, Journal of Biological Chemistry.

[22]  C. Garlanda,et al.  Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response , 2002, Nature.

[23]  M. Moore,et al.  Uptake of Aspergillus fumigatus Conidia by Phagocytic and Nonphagocytic Cells In Vitro: Quantitation Using Strains Expressing Green Fluorescent Protein , 2002, Infection and Immunity.

[24]  J. Jensenius,et al.  Substrate Specificities of Recombinant Mannan-binding Lectin-associated Serine Proteases-1 and -2* , 2001, The Journal of Biological Chemistry.

[25]  E. Mellado,et al.  Inoculum Standardization for Antifungal Susceptibility Testing of Filamentous Fungi Pathogenic for Humans , 2001, Journal of Clinical Microbiology.

[26]  N. Rawal,et al.  Formation of High-Affinity C5 Convertases of the Alternative Pathway of Complement1 , 2001, The Journal of Immunology.

[27]  W. Watford,et al.  Complement-mediated host defense in the lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[28]  N. Rawal,et al.  Formation of high-affinity C5 convertases of the alternative pathway of complement. , 2000, Journal of immunology.

[29]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[30]  E. Prossnitz,et al.  Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships , 1997, Journal of leukocyte biology.

[31]  J. Latgé,et al.  Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. , 1992, The Journal of infectious diseases.

[32]  H. Malech,et al.  Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. , 1990, The Journal of infectious diseases.

[33]  M. Collins,et al.  Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis , 1990, Infection and immunity.

[34]  S. Levitz,et al.  Human Neutrophil Degranulation Stimulated by Aspergillus fumigatus , 1990, Journal of leukocyte biology.

[35]  M. A. Wilson,et al.  Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae , 1989, Infection and immunity.

[36]  M. Turner,et al.  The role of opsonins in vacuolar sealing and the ingestion of zymosan by human neutrophils. , 1986, Immunology.

[37]  R. Diamond,et al.  Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia , 1985, Infection and immunity.

[38]  B. Strom,et al.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.

[39]  R. Clark,et al.  Damage to Aspergillus fumigatus and Rhizopus oryzae Hyphae by Oxidative and Nonoxidative Microbicidal Products of Human Neutrophils In Vitro , 1982, Infection and immunity.

[40]  R. Lehrer,et al.  Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum , 1970, Infection and immunity.

[41]  V. Devita,et al.  Aspergillosis. The spectrum of the disease in 98 patients. , 1970, Medicine.

[42]  C. Hack,et al.  Functional characterization of the lectin pathway of complement in human serum. , 2003, Molecular immunology.